Skip to NavigationSkip to content

Pharmafile - Sales and Marketing News

The approval covers a range of RMS variants, including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive...
Japan’s Ministry of Health, Labour and Welfare has awarded approval to AstraZeneca’s Lokelma for the treatment of hyerkalaemia, marking the first...
Pfizer announced that the FDA has approved its supplemental New Drug Application for EUCRISA ointment in treating 3 month year old children with mild...
President Trump has continually touted the effectiveness of anti-malaria drug Hydroxychloroquine in treating coronavirus which has led to a jump in...
As the first step on the partnership, Silence will receive an initial investment of $60 million in cash from AZ, while the latter will also subscribe...
The FDA has chosen not to approve an expanded indication of 2.5mg Jardiance (empaglifozin) as an adjunct to insulin in the treatment of type 1...
Dr Anthony Fauci, the Director of the National Institute of Allergy and Infectious Disease in the US, said that people between the ages of 20 and 44...
ViiV Healthcare has secured its first global approval for its once-monthly treatment Cabenuva, it has emerged, to replace current antiretroviral...
Researchers have used artificial intelligence to train algorithms to predict tumour sensitivity to systemic cancer therapies.
The Trump administration is not relaxing sanctions on Iran, despite the country having one of the highest death tolls from coronavirus.
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches